FDA approves Amerigen’s Temodar generic

SILVER SPRING, Md. — The Food and Drug Administration has approved Amerigen Pharmaceuticals’s generic of Temodar (temozolomide) capsules, the company announced Thursday. The drug is indicated to treat certain types of brain cancer. 

 

Amerigen’s generic has launched and is available in 5-, 2-, 100-, 140-, 180- and 250-mg dosage strengths.